Breaking News
July 23, 2018 - Vaxart Announces Publication of the Phase 1 Results of its Oral Norovirus Tablet Vaccine in Journal of Clinical Investigation Insight
July 23, 2018 - Joslin researchers report excessive fetal growth despite well-controlled type 1 diabetes
July 23, 2018 - Former inmates more likely to die of opioid overdose after prison release
July 23, 2018 - Doctors’ ‘gut feelings’ play key role in medical decision making, finds study
July 23, 2018 - Tooth enamel that regrows? Researcher says revolutionary gel could make it possible
July 23, 2018 - ECU researchers develop world’s first blood test that detects melanoma in its early stages
July 23, 2018 - Researchers explore future of houseplants as functional sirens of home health
July 23, 2018 - No Outcome Differences Based on Anesthesia Team Make-Up
July 23, 2018 - Getting to the heart of congenital cardiac defects
July 23, 2018 - Healthy behaviors are not effective in preventing gestational diabetes in obese women
July 23, 2018 - Top of Teachers’ To-Do List: Focus on the Positives
July 23, 2018 - LDL quality is a novel, modifiable cardiovascular risk marker
July 22, 2018 - Researchers identify enzyme as potential new drug target for blood disorders
July 22, 2018 - Research shows that neurons can encode more than one signal at a time
July 22, 2018 - Exposure to secondhand smoke increases the risk of stillbirth
July 22, 2018 - Skin conditions by the numbers
July 22, 2018 - Brain tumour chemotherapy now available to even more NHS patients
July 22, 2018 - Researchers find mugwort pollen as major source of airborne endotoxins
July 22, 2018 - Occupational safety and health at workplace
July 22, 2018 - Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain
July 22, 2018 - Early supper associated with lower risk of breast and prostate cancer
July 22, 2018 - Survey results identify major inequalities in acute stroke treatment across Europe
July 22, 2018 - Researchers discover promising treatment for genetic form of autism spectrum disorder
July 22, 2018 - Prenatal Depression More Common in Young Moms Today
July 22, 2018 - What helps adults with autism get and keep a job?
July 22, 2018 - Pediatric NEXUS Head CT DI guides selective imaging decisions in blunt trauma patients
July 22, 2018 - Novel tool predicts genes that cause disease due to production of truncated proteins
July 22, 2018 - AHA: Vaping Tied to Blood Clots — in Mice
July 22, 2018 - Study finds therapy dogs effective in reducing symptoms of ADHD
July 22, 2018 - Scientists find reason why malarial parasites are faster than immune cells
July 22, 2018 - Researchers gain more insight into how FUS protein causes ALS and FTLD
July 22, 2018 - Frequency of joint replacements halved in rheumatoid arthritis patients between 1997-2010
July 22, 2018 - QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies
July 22, 2018 - UK health communication researcher seeks solutions for disposing leftover medicine
July 22, 2018 - Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy Fidanacogene Elaparvovec
July 22, 2018 - Mutation discovered to protect against Alzheimer’s disease in mice
July 22, 2018 - Researchers reveal how patients in urban areas develop multiple, long-term conditions
July 22, 2018 - Replacing conventional cancer treatment with complementary therapy linked to increased risk of death
July 22, 2018 - Study uncovers molecular key for delaying progression of multiple sclerosis
July 22, 2018 - Availability of athletic trainer in high school reduces injury rates in girls’ sports, shows study
July 22, 2018 - FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
July 22, 2018 - Novel nuclear medicine probe will help assess new drugs for neurodegenerative diseases
July 22, 2018 - Physical activity even during exposure to air pollution can reduce risk of heart attack
July 22, 2018 - Scientists discover protein regulator of myelin production
July 22, 2018 - Sleep disturbances associated with higher dementia risk
July 22, 2018 - Scientists move one step further in developing eye drops to treat age-related macular degeneration
July 22, 2018 - Five-Year Stroke Rates Lower After PCI Versus CABG
July 21, 2018 - Alopecia areata – Genetics Home Reference
July 21, 2018 - Study identifies overdose risk factors in youth with substance use disorders
July 21, 2018 - Drug in clinical trials for Parkinson’s disease offers hope for treating heart failure
July 21, 2018 - Coupling free malaria tests with diagnosis-dependent vouchers can improve rational use of ACTs
July 21, 2018 - Sweetness depends on molecular interactions between specific sugars and water in saliva
July 21, 2018 - Muscle fitness is strongly associated with improved rate of ageing in the brain
July 21, 2018 - Resetting E-Prescriptions for Opioids Helps Curb Use: Study
July 21, 2018 - Overuse of antibiotics not what the doctor ordered
July 21, 2018 - Bundled-payment system did not lower costs for serious medical conditions, shows study
July 21, 2018 - Therapy dogs found to be effective in reducing ADHD symptoms in children
July 21, 2018 - Could rotating multiple therapists better treat PTSD patients?
July 21, 2018 - Binge drinking impairs working memory in adolescent brain
July 21, 2018 - Dying at home could be beneficial for terminally ill cancer patients and their relatives
July 21, 2018 - Researchers identify subtypes of retinal ganglion cells using single-cell RNA sequencing
July 21, 2018 - Study uncovers opportunities to reduce death by suicide among cancer patients
July 21, 2018 - Genetic sequencing reveals new clues to aggressiveness of prostate cancer
July 21, 2018 - BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
July 21, 2018 - First major study comparing robotic to open surgery published in The Lancet
July 21, 2018 - ADHD medications may fail to improve cognition in healthy college students, study shows
July 21, 2018 - Intervention program that includes a personalized app could benefit teens with suicidal thoughts
July 21, 2018 - Researchers identify new compound that protects against neurodegeneration
July 21, 2018 - Gene therapy may hold potential to treat people with spinal cord injuries
July 21, 2018 - FDA Approves Nivestym (filgrastim-aafi), a Biosimilar to Neupogen
July 21, 2018 - Surgeons have substantial impact on genetic testing in breast cancer patients who need it
July 21, 2018 - Species diversity can have positive and negative impacts on disease transmission
July 21, 2018 - Genome research suggests presence of enteric fever in medieval Europe
July 21, 2018 - Risk of Sensory Deficits Drops With Rising Gestational Age
July 21, 2018 - Mum’s sleep matters—the effect of sleep on an unborn baby
July 21, 2018 - UC San Diego researchers awarded two grants for investigating stem cell-based therapies
July 21, 2018 - Cellular ‘garbage disposal’ may actually work on some of the proteins to neuronal development
July 21, 2018 - More Pregnant Women Having Heart Attacks
July 21, 2018 - Acne Breakouts | NIH News in Health
July 21, 2018 - Change health messaging to focus on potential impact to help stop the next pandemic
Web-Based Personalized Intervention May Reduce RA Risk

Web-Based Personalized Intervention May Reduce RA Risk

image_pdfDownload PDFimage_print

Action Points

  • A personalized medicine approach that translates epidemiologic findings about genetics, biomarkers, and behavior into a personal, web-based intervention may help people reduce their risk of rheumatoid arthritis (RA).
  • Note that individuals with the highest lifetime RA risk were most motivated to improve behavior, despite learning about non-modifiable factors like age, sex, genetics, and autoantibodies.

A personalized medicine approach that translates epidemiologic findings about genetics, biomarkers, and behavior into a personal, web-based intervention appeared to help people reduce their risk of rheumatoid arthritis (RA), according to new research from Brigham and Women’s Hospital and Harvard Medical School in Boston.

First-degree relatives of RA patients who received personalized disclosure and education about RA were 23% more likely to increase their motivation to improve risk-related behaviors over 6 months compared with those who received standard, non-personalized education (RR 1.23, 95% CI 1.01-1.51, P=0.043), reported Jeffrey Sparks, MD, MMSc, and colleagues, writing online in Arthritis Care and Research.

Compared with those who received standard RA education, relatives who received personalized information reported increasing their fish intake (45% versus 22.1%, P=0.005), brushing their teeth more frequently (40.7% versus 22.9%, P=0.01), flossing more frequently (55.7% versus 34.8%, P=0.004), and quitting smoking (62.5% versus 0.0% among 11 smokers, P=0.18). Individuals with the highest lifetime RA risk were most motivated to improve behavior, despite learning about non-modifiable factors like age, sex, genetics, and autoantibodies.

“Genetic risk disclosure alone has had limited impact on other health behavior changes,” the team wrote. “Our study is one of the few to evaluate the effect of factors beyond genetics by including the impact of biomarkers, demographics, and behavioral risk factors to motivate positive health behaviors changes.”

Having a first-degree relative with RA increases personal RA risk by four times, and while both genetic and behavioral RA risk factors are shared within families, choice plays an important role. “The population attributable risk for RA of known behavioral factors is about 40%, suggesting that improving these health behaviors may reduce risk of developing RA. Intention to change behavior is the first step toward persistent behavior change, which may subsequently lead to demonstrable effects on health outcomes such as autoantibody development or RA risk.”

In this proof-of-concept trial, the researchers recruited unaffected parents, children, and siblings of RA patients at Brigham and Women’s Hospital from 2013 to 2016. Excluded were relatives who were older than age 70 or who had symptoms or a diagnosis of any systemic rheumatic disease.

The investigators incorporated a Personalized Risk Estimator for RA (PRE-RA) into the study, a web-based tool they had previously designed to disclose personalized RA risk based on genetics, biomarkers, demographics, and risk-related behavior. Four behavioral factors were included in the RA risk estimate: cigarette smoking, excess body weight, poor oral health, and low fish intake. The tool showed participants their genetic (HLA-DRB1) and autoantibody (rheumatoid factor and cyclic citrullinated peptide) results, presented relative and absolute lifetime risk of RA, and provided personalized education to modify behavior.

Participants were randomized to one of three groups:

  • The comparison arm (n=80) received non-personalized, standard education about RA epidemiology, symptoms, and diagnosis
  • The PRE-RA arm (n=78) received the web-based PRE-RA risk disclosure and education tool
  • The PRE-RA Plus arm (n=80) received the PRE-RA tool plus a 45-minute session with a health educator who helped interpret findings and taught participants about changing risk-related behavior

Most participants were female (76.5%), white (87.0%), and had greater than high school education (87.8%). Mean age was 43.4 in the comparison group and 46.7 in the PRE-RA groups.

The primary outcome was readiness for change in four areas associated with RA risk — smoking, diet, exercise, and dental hygiene — using the transtheoretical model (TTM) of behavior change. TTM, a tool developed by James Prochaska, PhD, director of the Cancer Prevention Resource Center at the University of Rhode Island, assesses how ready an individual is to make healthier choices. The tool includes a contemplation ladder with rungs corresponding to stages of motivation progressing through pre-contemplation, contemplation, preparation, action, and maintenance, and was validated originally in studies of behavioral changes in smokers.

Sparks and colleagues defined increased motivation to improve as an increase in any ladder score compared with baseline. The team also evaluated self-reported changes in RA risk-related behaviors as secondary outcomes.

For the primary analysis, the researchers combined the two PRE-RA arms into a single group (n=158). Over three time points — immediately, 6 weeks, and 6 months after intervention — those in the PRE-RA group were more likely to increase motivation to improve behavior than those in the comparison arm (age-adjusted RR 1.23, 95% CI 1.01-1.51, P=0.043).

Individuals in the PRE-RA group were also more likely to have ≥1 point increase in the dental hygiene ladder than those in the comparison group (26.3% versus 14.1%; age adjusted difference of 12.6%, 95% CI 2.6-22.5%, P=0.014). The proportion of participants who had an increase in diet and exercise ladders was similar between the PRE-RA group and the comparison arm.

At 6 months post-intervention, more individuals in the PRE-RA group reported brushing and flossing teeth more frequently, increasing fish intake, and stopping smoking than those in the comparison group. At all time points, the web-based PRE-RA tool performed similarly well with or without a health educator.

These results provide a rationale for larger studies evaluating the effect of behavior changes on clinical outcomes like autoantibody production or RA development, the researchers said

Regarding study limitations, Sparks and colleagues said that due to the trial’s nature, it was not possible to blind the participants to their educational intervention. In addition, since most of the participants were well-educated women, the results might not be generalizable to other populations. Furthermore, the outcomes were self-reported, so participants actually might not have improved behaviors.

This research was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

No conflicts of interest were noted

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-10-23T15:30:00-0400

Tagged with:

About author

Related Articles